High levels of exposure to phthalates have been associated with an increased risk for adverse male fetal reproductive development. Although animal studies have consistently demonstrated reproductive health effects, additional human epidemiological studies are needed to fully understand the potential harm to humans. Recent findings reported for humans have demonstrated endocrine -disrupting action similar to that associated with phthalate exposures in animals. As a result, phthalate exposure is an emerging public health concern that warrants further review. This article explores the state of the science on phthalate exposure, reviews the literature, and provides recommendations occupational health nurses can use to optimize the health of susceptible populations.
of the penis to the anus), and an increased likelihood of undescended testes, which increases the risk for testicular cancer and infertility (Marsee, Woodruff, Axelrad, Calafat, & Swan, 2006; Swan et aI., 2005) .
Phthalates are found in common consumer products such as perfume. deodorant. nail polish , shampoo. food wrap, and cosmetics (Environmental Working Group , 2(00). Phthalates are industrial chem icals that are used in a wide variety of plastic products to provide flexibility and pliability to plastics by allowing polymer molecules to slide against each other. Due to their adaptable characteristics. phthalates are useful ingredients in cosmetic and beauty products (Environmental Working Group, 2(00). Manufacturers use low molecular weight phthalates such as di-n-butyl phthalate (DBP) and di-ethyl phthalate (DEP)as solvents; these phthalates are versatile and produce oily textures in lotions. contributing to softening of and deeper penetration into the skin. DEP is one of the most common and essential ingredients in scented products, causing fragrances to last longer (Environmental Working Group, 2(00).
Phthalates are rapidly metabolized by hydrolysis and subsequent oxidation reactions and are excreted in the urine (Wittassek & Angerer, 2008) . The content of phthalate metabolites in human urine represents a measure of recent internal exposure to the parent phthalate. Phthalates have multiple routes of exposure, including ingestion, inhalation, and dermal contact, all of which must be considered during exposure assessment. The relative contribution of individual phthalates from various sources and routes of exposure is unknown (Wormuth, Scheringer, Vollenweider, & Hungerbuhler, 2006) .
REVIEW OFTHE LITERATURE

Animal Studies
Research has demonstrated that the active parent compound's first breakdown product, the phthalate metabolite, causes harm to the male reproductive system. Fetal exposure during a critical period in late gestation has been linked with adverse reproductive outcomes-hypospadias, undescended testes, and reduced sperm countin developing rats (Carruthers & Foster, 2005; Environmental Working Group, 2000; Foster, 2006) . Damaging effects on the Sertoli cells, which affect spermatogenesis, have also been documented in rodents (Sjoberg, Bondesson, Sedin, & Gustafsson, 1985) . The higher levels of phthalates in laboratory experiments with rodents have been linked to a suppression of estradiol production in the ovaries and resulting anovulation-a common cause of female infertility (Lovekamp- Swan & Davis, 2003) . Animal studies report that di-(2-ethylhexyl) phthalate (DEHP) and DBP are linked to a significant reduction in fetal testosterone and insulin-like growth factor 3, resulting in a syndrome of male reproductive abnormalities (Foster, Cattley, & Mylchreest, 2000; Gray et aI., 2006) .
Human Studies
General Population Exposure. Exposure in the general population has been assessed by measuring phthalate metabolites in human urine samples (Silva et aI., 2004; Wittassek & Angerer, 2008) . The National Health and Nutrition Examination Survey (NHANES), an ongoing national study conducted by the CDC, is designed to evaluate the health and nutritional status of the U.S. population. Through the NHANES, the CDC collects urinary metabolite data for the general population. The NHANES provides nationally representative population-based urinary phthalate metabolite data, based on one specimen per participant, for selected demographic groups in the United States. Urinary metabolite biomarkers have uncovered differences based on age, gender, and race (Blount et aI., 2000; Silva et aI., 2004) . The significance of phthalate exposures has also been noted in the NHANES III. This survey measured urinary phthalate metabolites in 1,029 volunteers in 12 locations in the United States, finding elevated levels of DBP among women of childbearing age (Blount et al., 2000) . Women of reproductive age, 20 to 40 years old, had significantly higher levels of mono-n-butyl (MBP) than other age and gender groups. Concentrations of certain urinary phthalate metabolites, specifically MBP, mono-benzyl (MBzP), and mono-(2ethylhexyl) phthalate (MEHP), were higher in the youngest age group, 6 to 11 years, and decreased with age. This AAOHN JOURNAL' VOL. 59, NO.5, 2011
is not unexpected, as phthalate metabolite concentrations tend to be higher in young children compared to other age groups (Wormuth et al., 2006) . The higher levels of metabolites among the younger age group are believed to be from sucking or chewing on plastic toys or playing close to the floor or outside on playgrounds (Shea & American Academy of Pediatrics Committee on Environmental Health, 2003) . Higher metabolite concentrations among women of reproductive age are assumed to be due to their greater than average use of personal care products (Koo & Lee, 2004) . These data provide evidence that phthalate exposure is higher and more common than expected; thus, exposure data among potentially susceptible populations are critical.
The NHANES biomonitoring study provides a more accurate estimate of the magnitude of exposures, as it is based on actual measurements of phthalates in humans. However, the measurement of exposures to nonpersistent chemicals such as phthalates is affected by substances being metabolized quickly and concentrations changing rapidly over time (Wittasek & Angerer, 2008) . Further, exposure measurements are often based on a single sample at a particular date and time and do not provide information about the timing of exposure in particular individuals or populations. As a result, biomonitoring data cannot be used alone to provide the basis for determining the source for particular phthalates or populations; thus, further studies are needed. Also, children younger than 6 years and individuals 60 years and older were not represented in the NHANES population sampled. Prenatal exposure data were not collected (Blount et aI., 2000) .
Phthalate Exposures From Personal Care Products. Despite the compelling evidence from animal studies, few studies of humans exposed to phthalates have been conducted. Duty, Ackerman, Calafat, and Hauser (2005) explored the relationship between patterns of personal product use and urinary levels of phthalate metabolites among 406 men participating in a semen quality study. A nurse-administered questionnaire was employed to determine the use of personal care products, including cologne, aftershave, lotions, hair products, and deodorant. Increased phthalate monoester concentrations were found among men who used cologne or aftershave. Overall, these men had higher median levels of the metabolite monoethyl phthalate (MEP) (265 and 266 ng/mL, respectively) than those who did not use cologne or aftershave (108 and 133 ng/mL, respectively). For each additional type of product used, MEP level increased 33% (95% confidence interval, 14% to 53%) (Duty et al., 2005) .
This study suggests that cumulative use of products contributes to higher cumulative phthalate levels. This study identified personal care products as a contributor to phthalate body burden, a crucial step in exposure characterization. However, the sample consisted of only men. Women of childbearing age are of particular concern, as they presumably have higher levels of exposure than the general population (CDC, 2005) . This study was subject to recall bias because participants were asked to recall products used in the previous 48 hours. Researchers did not control for confounders (e.g., occupation) that may have an impact on exposure levels. This study also did not monitor air levels, which could playa significant role in exposure via ingestion or inhalation in relation to urine metabolite levels (Duty et al., 2(05) . The extent of phthalate exposures via inhalation is not known (Kwapniewski et al., 2(08) . Results of this study indicate the need to identify occupational groups susceptible to phthalate exposures. For example, massage therapists or beauty salon workers may use multiple products throughout a workday, contributing to higher than average phthalate exposures.
Another recent study analyzed the contribution of exposure to personal care products to phthalate metabolites in 163 infants born between 2000 and 2005 (Sathyanarayana et al., 2(08). An infant was considered exposed to any infant care product that the mother reported using on her infant within 24 hours of urine collection. Infants' levels of MEP and MBP were found to be directly related to the number of infant care products (i.e., lotions, creams, and powders) applied by their mothers (Sathyanarayana et al., 2(08) . This was the first study to analyze phthalate exposure from personal care products and the contribution of these products to phthalate body burden among infants. However, the phthalate content of specific products was unknown because manufacturers are not required to list phthalates. The questionnaire did not evaluate the amount of product used; thus, although dose response could be determined based on the number of products used, the actual amount of product used was not assessed. Also, potential recall bias existed because mothers were required to report products used on their infants within 24 hours of urine collection.
Occupational Exposure to Phthalates. Only one previous study has examined the personal care product and phthalate body burden from occupational exposure (Kwapniewski et al., 2(08) . This study included manicurists. DBP is also used in nail polish to maintain color and prevent chipping. Kwapniewski et al. (2008) measured manicurists' exposure to DBP at work and explored whether workplace characteristics (i.e., ventilation, eating in the salon, using gloves) influenced this exposure. Although not statistically significant, manicurists working in a setting without ventilation had a 54% increase in urinary cross-shift MBP concentration, compared to a 7% decrease among manicurists working in settings with exhaust fans. Further exploration of these variables is needed because the analysis was underpowered and wide variability in urinary cross-shift MBP concentration was found (Kwapniewski et al., 2(08) . Glove use was associated with a significant reduction in urinary cross-shift MBP concentrations (p =.04). Kwapniewski et al. (2008) also discovered a statistically significant increase in urinary cross-shift concentrations of phthalate metabolites.
The study by Kwapniewski et al. (2008) had a crosssectional design in which the exposure and outcome were assessed simultaneously. This was an unusual, understudied population of manicurists. The self-reported questionnaire allowed the researchers to examine several variables inexpensively. A weakness of this study was the sampling frame of manicurists interested in participating in the study may have been sufficiently different from the target population. Also, the researchers did not monitor personal air levels, which could play an important role in exposure via ingestion or inhalation in relation to urine metabolite levels (Duty et al., 2(05) . Volunteers may have had work practices different from those of nonvolunteers. Use of personal skin care products was a potential confounder that was not controlled in this study. Further studies among other occupational groups are needed. The proposed study controls for potential confounding from the use of personal skin care products and monitors air and urine levels to quantify workplace phthalate exposures.
A recent Chinese study compared 74 men who manufactured polyvinyl chloride (PVC) flooring at a plant in Liaoning Province to 63 men employed at a construction company (Pan et al., 2006) . The men completed questionnaires on lifestyle factors. Blood samples were analyzed for circulating free testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH). Urinalysis provided data on concentrations of MBP and MEHP, which served as biomarkers of exposure. PVC plant workers had lOO-fold higher levels of MBP and MEHP and significantly lower blood testosterone concentrations than construction workers. These findings are concerning, suggesting that phthalates have a direct impact on men's hormone levels, which may ultimately impact their fertility. Thus, researchers need to identify other highrisk occupational groups and attempt to characterize their exposure levels to prevent potential health effects (Pan et al., 2006) . The inverse relationship between MBP and testosterone levels in this study appears to be consistent with studies of male infants in which MBP concentrations were inversely associated with anogenital index (a measure of androgen activity) and free serum testosterone (Main et al., 2006; Swan et aI., 2(05) .
This was the first study to evaluate the effect of phthalates on reproductive function in a high-risk occupational group. It provided a cross-sectional analysis of the potential impact phthalate exposure has on reproductive hormone levels. However, phthalate and hormone levels were determined from single spot urine and blood samples. Minute-to-minute variations in endogenous serum LH and FSH concentrations may have occurred, potentially biasing the results by misrepresenting average hormone levels (Pan et al., 2(06) .
Fetal Exposures. The fetus is particularly susceptible to developmental and reproductive toxicity due to its critically sensitive life stage. Various sources of DEHP exposure place neonates at increased risk of toxicity and subsequent potential adverse effects. Higher levels of DEHP have been associated with multiple exchange transfusions (Sjoberg et al., 1985) . One study demonstrated elevated urinary levels of the metabolite MEHP in infants in the neonatal intensive care unit after health care devices containing DEHP (i.e., umbilical vessel catheterization, endotracheal intubation) were used (Green et al., 2(05) . Factors such as prematurity and young postnatal age have been hypothesized to decrease the rate of DEHP clearance from infants' bodies (Hillman, Goodwin, & Sherman, 1975) . Loff et al. (2000) found that infusion lines could leach significant amounts of phthalates dur-ing long-term total parenteral nutrition, which supplies all daily nutrition to infants who cannot digest food via the gastrointestinal tract. The investigators found that exposure to DEHP can be higher for infants who receive total parenteral nutrition solutions than infants who receive routine intravenous solutions. Rates of DEHP leaching also increased at higher incubator temperatures. This study revealed that infants in the neonatal intensive care unit are likely exposed to higher levels of DEHP as a result of higher incubator temperatures, commonly used to maintain body temperature (Loff et al., 2000; Pak, Nailon, & McCauley, 2007) . As a result of these studies, the U.S. Food and Drug Administration (FDA) has classified infants in neonatal intensive care units as being at high risk of exposure. Hospitals may determine whether to replace equipment containing DEHP with DEHP-free alternatives or continue an older protocol (FDA, 2002) . The approach taken by many hospitals of opting for DEHP-free equipment should be applied to the issue of common personal care products containing DEP and DBP, as the long-term consequences of aggregate chronic low-dose exposures to these compounds are unknown and vulnerable populations remain at risk. Main et al. (2006) correlated reproductive hormone levels at 3 months of age to the concentration of six phthalate monoesters in breast milk, the major source of nutrition for infants worldwide. The authors discovered that phthalate exposure through breast milk was associated with abnormal reproductive hormone levels in 3-month-old infants, suggesting that early human exposures may have an adverse impact on endocrine homeostasis (Main et al., 2006) . Despite the hormone changes in boys and phthalate monoester levels in breast milk, the authors could not conclude that fetal exposure contributed to altered postnatal hormone levels. The levels of phthalate monoesters in breast milk may be a proxy for general maternal exposure. Women with high levels of phthalate monoesters in breast milk may also be among those with the highest exposures during pregnancy, creating a challenge to ruling out fetal exposures because phthalates may cross the placental barrier (Latini et al., 2003; Main et al., 2006) . Future studies must take into account fetal and maternal exposures to phthalates and infant hormone and breast milk levels to control for fetal exposures and more accurately explore the link between exposures to phthalates via breast milk and subsequent hormonal changes in infants.
Reproductive Effects. Swan et al. (2005) have identified a statistically significant relationship between mothers' exposure to phthalates during pregnancy and changes in male infants' genital development. The investigators reported that a sensitive marker of demasculinization of the male reproductive tract, the anogenital index, was significantly related to phthalate exposure. Women included in the study were recruited during the first phase of a multicenter pregnancy cohort study at prenatal clinics in Los Angeles, California, Minneapolis, Minnesota, and Columbia, Missouri, between 1999 and 2002 . A total of 346 mothers and 176 infants participated in the study; urine samples were available for AAOHN JOURNAL· VOL. 59. NO.5, 2011 most of the women from the previous study. Eighty-five prenatal urine samples from the mothers were analyzed for nine phthalate metabolites by scientists at the CDC. The anogenital index, defined as the anogenital distance divided by the weight of the male infant at examination, allowed investigators to compare male infants at different ages and weights. Of the nine phthalate metabolites measured, DBP and DEP were two of the three metabolites that showed significant inverse correlations with anogenital index. The investigators created a "summary phthalate score" to reflect simultaneous exposures to multiple phthalates. The higher the score, the more total phthalate exposure occurred. The summary phthalate score was directly related to the proportion of male infants with a lower anogenital index (p = .001). Mothers who have higher phthalate levels in their urine are more likely to give birth to male infants with shorter anogenital distances, which indicate testosterone repression, and undescended testes, which increase the risk for testicular cancer and infertility (Swan et al., 2005) .
The study by Swan et al. (2005) was the first human study to explore reproductive effects, using the anogenital index, of in utero exposures to phthalates. In animals, a shorter anogenital distance results from interference with androgens such as testosterone. Also, a combined phthalate score was used to explore additive risk. The CDC has demonstrated that the general population is exposed to measurable levels of multiple phthalates, and the additive effect of these chronic low-dose exposures is unknown. The score used in this study suggests joint exposure may represent greater than additive risk, although larger sample sizes are needed to confirm this. However, in this study, maternal data that may have contributed to phthalate exposure in utero (e.g., mother's occupation) were missing. Phthalate levels were based solely on a single sample per individual, which may not be representative of the average exposure level throughout pregnancy. The timing of fetal development in relation to exposure was not indicated. The lack of these exposure data could misrepresent fetal exposure levels that may impact critical periods of development. Despite these weaknesses, this was the first study to test the hypothesis that prenatal phthalate exposure is associated with anti-androgenic action. The study was small and must be replicated. Additional studies are needed to eliminate potential sources of exposure misclassification. Marsee et al. (2006) used a pharmacokinetic model to estimate individual daily exposure to phthalates among women from the study population of Swan et al. (2005) . They concluded that the levels of phthalates measured in these mothers and resulting in their infants' developmental effects were substantially beneath current safety standards established by the U.S. Environmental Protection Agency (EPA) (Marsee et al., 2006) . The EPA classifies phthalates as an air toxic, a volatile organic compound, and a water priority pollutant (EPA, n.d.) . The median and 95th percentiles of daily exposures of DBP in the study sample were 0.99 and 2.8 ug/kg/day, respectively, with DEP found to be 6.64 and 112.3 ug/kg/day, respectively. EPA reference doses are 100 ug/kg/day for DBP
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4 Occupational health nurses may educate potentiallyhigh risk occupational groups to use phthalate-free products. and 800 ug/kg/day for DEP. The oral reference dose is based on the assumption that thresholds exist for certain toxic adverse effects and is an estimate of human daily exposure likely to carry no appreciable risk of deleteriou s effects during a lifetime. The 95th percentile estimate is particularly significant because it demonstrates that 95% of women had estimated DEP and DBP exposure levels far below the EPA's reference dose (Marsee et al., 2006; , yet their infants remained at risk for toxic effects. Although this study suggests a need for revision of EPA standards, the agency has not yet revised the safe dose (Environmental Working Group, 2006) . In the meantime, efforts to increase the public's knowledge of the issue should guide individual decisions for action.
Although human infant studies demonstrate possible associations between phthalates and the development of the reproductive system , follow-up studies are needed. Rais-Bahrami , Nunez, Revenis, Luban, and Short (2004) examined the potential long-term toxicity and related adverse effects from DEHP exposure secondary to extracorporeal membrane oxygenation (ECMO) therapy. The study sample included 13 boys and 6 girls 14 to 16 years old who had undergone ECMO as neonates. Study participants underwent a complete physical examination, including measurements for height, weight, and head circumference. This study revealed that adolescents exposed to significant quantities of DEHP through PVC as neonates showed no significant adverse effects related to physical growth and pubertal maturity. Thyroid, liver, renal, and male and female gonadal functions were also within normal limits for age and gender distributions (Rais-Bahrami et al., 2004) .
The study by Rais-Bahrami et al. ( 2004) evaluated the relationship between early phthalate exposure and neonatal health outcomes and temporal sequencing between exposure and disease. A limitation of this study was that when DEHP enters the body, it is metabolized into various substances and rapidly excreted. The authors did not indicate how long each of these neonates received ECMO , impacting phthalate exposure time. Also , premature infants do not commonly receive ECMO because of their extremely small vessels (Betit & Craig, 2009 ). Thus, the infants in this study may not have been as vulnerable to the effects of phthalates. The rate of oxidation and glucuronide conjugation of DEHP in infants depends on the maturity of the liver (Plonait, Nau, Maier, Wittfoht, & Obladen, 1993) . The infants in this study may have had more mature glucuronidation processes that allowed them to eliminate DEHP faster and thus prevent adverse effects . Although no long-term effects from previous DEHP exposure were found in this study, continued monitoring is essential and prospective studies with larger sample sizes are needed to strengthen this conclusion. Prospective studies of previously studied neonates with presumed high in utero exposures, a critical time of exposure, to various phthalates also are needed to fully assess the potential for reproductive effects.
IMPLICATIONS FOR OCCUPATIONAL HEALTH NURSES
The review of key literature reveals gaps in understanding the potential adverse effects of exposure to phthalates. Despite animal studies demonstrating consistent reproductive toxicity, additional human studies are needed to explore health outcomes, especially affecting reproductive health. Current research demonstrates that human exposures to phthalates are ubiquitous, due in part to the lack of regulation of phthalates in common personal care products. The potential adverse effects of exposure to these chemicals for humans may not manifest until years later. Prospective studies are needed and populations at high risk for exposure, such as occupational groups, must be identified to prevent adverse outcomes and proceed in a cautionary manner. Occupational health nurses can advocate for additional research to identify susceptible occupational groups.
Although high phthalate exposures have been evaluated among susceptible populations such as women of childbearing age, high-risk occupational groups have not been well studied. Potential high-risk occupational groups include workers in PVC plants, massage therapists, and nail and beauty salon employees . Occupational health nurses should be aware of these high-risk occupational groups and their potential for adverse reproductive effects. Occupational health nurses can educate high-risk occupational groups to use phthalate-free products, available alternatives found in retail stores. These products are labeled "phthalate-free." Occupational health nurses can advocate for legislation mandating workplace safety inspections among susceptible populations (Pak & Me-Cauley, 2007) . Once the sources, extent, and routes of phthalate exposures are understood, specific environmental controls may be instituted to reduce them. Workplace accommodation may playa role in preventing adverse effects among workers at high risk for phthalate exposure. As workers and consumers attempt to reduce phthalate exposure, it is crucial that occupational health nurses know the risks and available alternatives.
